Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

What symbol and exchange does Agenus shares trade?

Agenus trades on the NASDAQ stock market under the symbol AGEN.

What is Agenus stock price doing today?

As of October 30, 2026, AGEN stock price declined to $6.84 with 527,099 million shares trading.

What is Agenus's Beta?

AGEN has a beta of 1.28, meaning it tends to be more sensitive to market movements. AGEN has a correlation of 0.03 to the broad based SPY ETF.

How much is Agenus worth?

AGEN has a market cap of $308.91 million. This is considered a Small Cap stock.

How much money does Agenus make?

Last quarter Agenus reported $35 million in Revenue and -$.01 earnings per share. This beat revenue expectation by $500,000 and exceeded earnings estimates by $.30.

What is the highest and lowest price Agenus traded in the last 3 year period?

In the last 3 years, AGEN traded as high as $19.69 and as low as $1.38.

What are the top ETFs holding Agenus?

The top ETF exchange traded funds that AGEN belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

Is Agenus (AGEN) a good investment?

AGEN has outperformed the market in the last year with a price return of +79.5% while the SPY ETF gained +12.3%. However, in the short term, AGEN had mixed performance relative to the market. It has underperformed in the last 3 months, returning -13.5% vs +2.1% return in SPY. But in the last 2 weeks, AGEN shares have fared better than the market returning +13.2% compared to SPY -1.0%.

What are the support and resistance levels for Agenus (AGEN)?

AGEN support price is $6.69 and resistance is $7.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGEN shares will trade within this expected range on the day.